Dear Reader,
I just went on stage in front of a 40-foot video screen to show my followers a brand-new technology and stock I’m recommending.
It’s a company that’s at the forefront of perhaps the most important new technology in 50 years.
And it reminds me of three of the best calls I ever made.
- Intuitive Surgical. A company I recommended in 2004 when it brought robotics to surgery. The company became one of the five best stocks of the last 20 years.
- Tandem Diabetes Care. Its new insulin system propelled it from $4 when I gave a presentation on it to $74 in just one year.
- Immunogen. This one I recommended on May 11 this year. One day later, it jumped 144% on the release of Phase 3 data… making it the #1 mover in the entire market.
What did they all have in common?
All three brought new technologies to helping sick patients get better.
And the new stock I’m recommending does the same.
It is the first company in the world to bring an AI-designed drug to clinical trials.
And it is now working with some of the biggest companies in the world to develop treatments for ovarian and blood cancer, antiviral diseases, breast cancer, and much much more.
In fact, the company recently saved an 82-year old cancer patient that had taken six treatments of chemo previously – all failed.
So yes, this is my biggest new recommendation.
And I invite you to watch my new presentation on the company right here.
Good investing,
Alexander Green
Chief Investment Strategist, The Oxford Club
P.S. This company is less than $10 today… but Wall Street has been moving in quickly buying up millions of shares.
I don’t suggest waiting on this.
Watch my breakdown of the company here.
This ad is sent on behalf of The Oxford Club, 105 W. Monument Street Baltimore, MD 21201. If you would like to opt out from receiving offers from The Oxford Club, please click here.
